$SNGX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SOLIGENIX, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SOLIGENIX, INC.. Get notifications about new insider transactions in SOLIGENIX, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 04 2021 | SNGX | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Option Exercise | A | 1.28 | 60,000 | 76,800 | 60,000 | |
Dec 11 2020 | SNGX | SOLIGENIX, INC. | Guarino Jonathan L. | Chief Financial Off ... | Option Exercise | A | 2.34 | 40,000 | 93,600 | 40,000 | |
Dec 11 2020 | SNGX | SOLIGENIX, INC. | Straube Richard | CMO | Option Exercise | A | 2.34 | 40,000 | 93,600 | 40,000 | |
Dec 11 2020 | SNGX | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Option Exercise | A | 2.34 | 60,000 | 140,400 | 60,000 | |
Dec 11 2020 | SNGX | SOLIGENIX, INC. | Donini Oreola | CSO | Option Exercise | A | 2.34 | 70,000 | 163,800 | 70,000 | |
Sep 18 2020 | SNGX | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | A | 1.97 | 15,228 | 29,999 | 15,228 | |
Sep 18 2020 | SNGX | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 1.97 | 15,228 | 29,999 | 15,228 | |
Sep 18 2020 | SNGX | SOLIGENIX, INC. | RUBIN ROBERT J. | Director | Option Exercise | A | 1.97 | 15,228 | 29,999 | 15,228 | |
Sep 18 2020 | SNGX | SOLIGENIX, INC. | Parks Diane L. | Director | Option Exercise | A | 1.97 | 15,228 | 29,999 | 15,228 | |
Jun 19 2020 | SNGX | SOLIGENIX, INC. | Parks Diane L. | Director | Option Exercise | A | 1.76 | 13,500 | 23,760 | 13,500 | |
Jan 02 2020 | SNGX | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Option Exercise | A | 1.45 | 60,000 | 87,000 | 60,000 | |
Dec 13 2019 | SNGX | SOLIGENIX, INC. | Donini Oreola | SVP and CSO | Option Exercise | A | 1.24 | 60,000 | 74,400 | 60,000 | |
Dec 13 2019 | SNGX | SOLIGENIX, INC. | Straube Richard | SVP and CMO | Option Exercise | A | 1.24 | 30,000 | 37,200 | 30,000 | |
Dec 13 2019 | SNGX | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Option Exercise | A | 1.24 | 60,000 | 74,400 | 60,000 | |
Dec 13 2019 | SNGX | SOLIGENIX, INC. | Guarino Jonathan L. | Senior Vice Preside ... | Option Exercise | A | 1.24 | 10,000 | 12,400 | 10,000 | |
Nov 19 2019 | SNGX | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Buy | P | 0.93 | 2,000 | 1,850 | 22,917 | 20.9 K to 22.9 K (+9.56 %) |
Nov 19 2019 | SNGX | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Buy | P | 0.93 | 10,770 | 10,016 | 53,095 | 42.3 K to 53.1 K (+25.45 %) |
Sep 23 2019 | SNGX | SOLIGENIX, INC. | Parks Diane L. | Director | Buy | P | 0.93 | 14,940 | 13,870 | 14,940 | 0 to 14.9 K |
Sep 23 2019 | SNGX | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Buy | P | 0.94 | 4,000 | 3,740 | 20,917 | 16.9 K to 20.9 K (+23.64 %) |
Sep 11 2019 | SNGX | SOLIGENIX, INC. | Guarino Jonathan L. | Senior Vice Preside ... | Option Exercise | A | 0.97 | 40,000 | 38,800 | 40,000 | |
Sep 10 2019 | SNGX | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | A | 0.97 | 30,928 | 30,000 | 30,928 | |
Sep 10 2019 | SNGX | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | A | 0.97 | 30,928 | 30,000 | 30,928 | |
Sep 10 2019 | SNGX | SOLIGENIX, INC. | RUBIN ROBERT J. | Director | Option Exercise | A | 0.97 | 30,928 | 30,000 | 30,928 | |
Sep 10 2019 | SNGX | SOLIGENIX, INC. | RUBIN ROBERT J. | Director | Option Exercise | A | 0.97 | 30,928 | 30,000 | 30,928 | |
Sep 10 2019 | SNGX | SOLIGENIX, INC. | Pearson Mark E. | Director | Option Exercise | A | 0.97 | 30,928 | 30,000 | 30,928 | |
Sep 10 2019 | SNGX | SOLIGENIX, INC. | Pearson Mark E. | Director | Option Exercise | A | 0.97 | 30,928 | 30,000 | 30,928 | |
Sep 10 2019 | SNGX | SOLIGENIX, INC. | Parks Diane L. | Director | Option Exercise | A | 0.97 | 30,928 | 30,000 | 30,928 | |
Sep 10 2019 | SNGX | SOLIGENIX, INC. | Parks Diane L. | Director | Option Exercise | A | 0.97 | 30,928 | 30,000 | 30,928 | |
Sep 10 2019 | SNGX | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 0.97 | 30,928 | 30,000 | 30,928 | |
Sep 10 2019 | SNGX | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 0.97 | 30,928 | 30,000 | 30,928 | |
Jul 10 2019 | SNGX | SOLIGENIX, INC. | Pearson Mark E. | Director | Grant | A | 0.71 | 78,338 | 55,620 | 78,338 | 0 to 78.3 K |
Jul 08 2019 | SNGX | SOLIGENIX, INC. | Parks Diane L. | Director | Option Exercise | A | 0.87 | 1,500 | 1,298 | 1,500 | |
Apr 22 2019 | SNGX | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Buy | P | 0.73 | 10,000 | 7,274 | 16,917 | 6.9 K to 16.9 K (+144.57 %) |
Apr 22 2019 | SNGX | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Buy | P | 0.73 | 10,000 | 7,274 | 16,917 | 6.9 K to 16.9 K (+144.57 %) |
Apr 22 2019 | SNGX | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Buy | P | 0.72 | 5,000 | 3,577 | 42,325 | 37.3 K to 42.3 K (+13.40 %) |
Apr 22 2019 | SNGX | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Buy | P | 0.72 | 5,000 | 3,577 | 42,325 | 37.3 K to 42.3 K (+13.40 %) |
Jan 04 2019 | SNGX | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Option Exercise | A | 0.96 | 60,000 | 57,600 | 60,000 | |
Dec 14 2018 | SNGX | SOLIGENIX, INC. | Straube Richard | SVP and CMO | Option Exercise | A | 0.97 | 40,000 | 38,800 | 40,000 | |
Dec 14 2018 | SNGX | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Option Exercise | A | 0.97 | 60,000 | 58,200 | 60,000 | |
Dec 14 2018 | SNGX | SOLIGENIX, INC. | Donini Oreola | SVP and CSO | Option Exercise | A | 0.97 | 40,000 | 38,800 | 40,000 | |
Oct 18 2018 | SNGX | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Buy | P | 1.17 | 8,700 | 10,177 | 37,325 | 28.6 K to 37.3 K (+30.39 %) |
Oct 17 2018 | SNGX | SOLIGENIX, INC. | Pearson Mark E. | Director | Buy | P | 1.16 | 170,000 | 197,200 | 2,500,000 | 2.3 M to 2.5 M (+7.30 %) |
Oct 17 2018 | SNGX | SOLIGENIX, INC. | Pearson Mark E. | Director | Buy | P | 1.16 | 170,000 | 197,200 | 2,500,000 | 2.3 M to 2.5 M (+7.30 %) |
Sep 28 2018 | SNGX | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | A | 1.67 | 17,964 | 30,000 | 17,964 | |
Sep 28 2018 | SNGX | SOLIGENIX, INC. | RUBIN ROBERT J. | Director | Option Exercise | A | 1.67 | 17,964 | 30,000 | 17,964 | |
Sep 28 2018 | SNGX | SOLIGENIX, INC. | Pearson Mark E. | Director | Option Exercise | A | 1.67 | 17,964 | 30,000 | 17,964 | |
Sep 28 2018 | SNGX | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 1.67 | 17,964 | 30,000 | 17,964 | |
Sep 28 2018 | SNGX | SOLIGENIX, INC. | Brownlie Keith L | Director | Option Exercise | A | 1.67 | 17,964 | 30,000 | 17,964 | |
Aug 22 2018 | SNGX | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Buy | P | 1.42 | 3,530 | 5,012 | 28,625 | 25.1 K to 28.6 K (+14.07 %) |
Jul 25 2018 | SNGX | SOLIGENIX, INC. | Pearson Mark E. | Director | Option Exercise | A | 1.22 | 1,500 | 1,830 | 1,500 | |
Dec 11 2017 | DOR | SOLIGENIX, INC. | Straube Richard | SVP and CMO | Option Exercise | A | 2.01 | 35,000 | 70,350 | 35,000 | |
Dec 11 2017 | DOR | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Option Exercise | A | 2.01 | 80,000 | 160,800 | 80,000 | |
Dec 11 2017 | DOR | SOLIGENIX, INC. | Krumeich Karen R | SVP and CFO | Option Exercise | A | 2.01 | 35,000 | 70,350 | 35,000 | |
Dec 11 2017 | DOR | SOLIGENIX, INC. | Donini Oreola | SVP and CSO | Option Exercise | A | 2.01 | 35,000 | 70,350 | 35,000 | |
Dec 01 2017 | DOR | SOLIGENIX, INC. | Essetifin SPA | Buy | P | 2.12 | 16,416 | 34,802 | 293,510 | 277.1 K to 293.5 K (+5.92 %) | |
Dec 01 2017 | DOR | SOLIGENIX, INC. | Essetifin SPA | Sell | S | 2.12 | 16,416 | 34,802 | 0 | 16.4 K to 0 (-100.00 %) | |
Dec 01 2017 | DOR | SOLIGENIX, INC. | Essetifin SPA | Buy | P | 2.12 | 5,954 | 12,622 | 277,094 | 271.1 K to 277.1 K (+2.20 %) | |
Dec 01 2017 | DOR | SOLIGENIX, INC. | Essetifin SPA | Sell | S | 2.12 | 5,954 | 12,622 | 0 | 6 K to 0 (-100.00 %) | |
Dec 01 2017 | DOR | SOLIGENIX, INC. | Essetifin SPA | Buy | P | 2.12 | 271,140 | 574,817 | 271,140 | 0 to 271.1 K | |
Dec 01 2017 | DOR | SOLIGENIX, INC. | Essetifin SPA | Sell | S | 2.12 | 271,140 | 574,817 | 0 | 271.1 K to 0 (-100.00 %) | |
Jun 12 2017 | DOR | SOLIGENIX, INC. | Brownlie Keith L | Director | Option Exercise | A | 2.29 | 13,100 | 29,999 | 13,100 | |
Jun 12 2017 | DOR | SOLIGENIX, INC. | Brughera Marco Maria | Director | Option Exercise | A | 2.29 | 13,100 | 29,999 | 13,100 | |
Jun 12 2017 | DOR | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 2.29 | 13,100 | 29,999 | 13,100 | |
Jun 12 2017 | DOR | SOLIGENIX, INC. | RUBIN ROBERT J. | Director | Option Exercise | A | 2.29 | 13,100 | 29,999 | 13,100 | |
Jun 12 2017 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | A | 2.29 | 13,100 | 29,999 | 13,100 | |
May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Option Exercise | X | 0.80 | 250,000 | 200,000 | 0 | |
May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.54 | 1,881 | 4,778 | 85,397 | 87.3 K to 85.4 K (-2.16 %) |
May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.70 | 13,893 | 37,511 | 87,278 | 101.2 K to 87.3 K (-13.73 %) |
May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.97 | 2,278 | 6,766 | 101,171 | 103.4 K to 101.2 K (-2.20 %) |
May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.54 | 9,695 | 24,625 | 440,418 | 450.1 K to 440.4 K (-2.15 %) |
May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.70 | 71,607 | 193,339 | 450,113 | 521.7 K to 450.1 K (-13.73 %) |
May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 2.97 | 11,739 | 34,865 | 521,720 | 533.5 K to 521.7 K (-2.20 %) |
May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Sell | S | 4.01 | 49,875 | 199,999 | 533,459 | 583.3 K to 533.5 K (-8.55 %) |
May 08 2017 | DOR | SOLIGENIX, INC. | KIRK RANDAL J | 10% Owner | Buy | X | 0.80 | 250,000 | 200,000 | 583,334 | 333.3 K to 583.3 K (+75.00 %) |
Dec 20 2016 | DOR | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Option Exercise | P | 3.95 | 19,755 | 78,032 | 19,755 | |
Dec 20 2016 | DOR | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Buy | P | 3.16 | 15,804 | 49,939 | 25,095 | 9.3 K to 25.1 K (+170.10 %) |
Dec 20 2016 | DOR | SOLIGENIX, INC. | RUBIN ROBERT J. | Director | Option Exercise | P | 3.95 | 3,956 | 15,626 | 3,956 | |
Dec 20 2016 | DOR | SOLIGENIX, INC. | RUBIN ROBERT J. | Director | Buy | P | 3.16 | 3,165 | 10,001 | 4,385 | 1.2 K to 4.4 K (+259.43 %) |
Dec 20 2016 | DOR | SOLIGENIX, INC. | Brughera Marco Maria | Director | Option Exercise | P | 3.95 | 2,500 | 9,875 | 2,500 | |
Dec 20 2016 | DOR | SOLIGENIX, INC. | Brughera Marco Maria | Director | Buy | P | 3.16 | 2,000 | 6,320 | 2,750 | 750 to 2.8 K (+266.67 %) |
Jun 22 2016 | DOR | SOLIGENIX, INC. | Krumeich Karen R | SVP and CFO | Option Exercise | A | 0.74 | 100,000 | 74,000 | 100,000 | |
Jan 04 2016 | DOR | SOLIGENIX, INC. | Warusz Joseph Michael | VP of Finance/Actin ... | Option Exercise | A | 1.13 | 55,000 | 62,150 | 55,000 | |
Jan 04 2016 | DOR | SOLIGENIX, INC. | Straube Richard | Senior VP and CMO | Option Exercise | A | 1.13 | 70,000 | 79,100 | 70,000 | |
Jan 04 2016 | DOR | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Option Exercise | A | 1.13 | 140,000 | 158,200 | 140,000 | |
Jan 04 2016 | DOR | SOLIGENIX, INC. | Donini Oreola | SVP and CSO | Option Exercise | A | 1.13 | 70,000 | 79,100 | 70,000 | |
Dec 23 2015 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Buy | P | 1.27 | 2,500 | 3,175 | 69,166 | 66.7 K to 69.2 K (+3.75 %) |
Dec 23 2015 | DOR | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Buy | P | 1.29 | 10,000 | 12,878 | 85,761 | 75.8 K to 85.8 K (+13.20 %) |
Aug 31 2015 | DOR | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Option Exercise | M | 0.30 | 25,000 | 7,500 | 0 | |
Aug 31 2015 | DOR | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Buy | M | 0.30 | 25,000 | 7,500 | 73,781 | 48.8 K to 73.8 K (+51.25 %) |
Jul 01 2015 | DOR | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Option Exercise | M | 0.61 | 7,143 | 4,357 | 0 | |
Jul 01 2015 | DOR | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Buy | M | 0.61 | 7,143 | 4,357 | 82,904 | 75.8 K to 82.9 K (+9.43 %) |
Jun 19 2015 | DOR | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 1.51 | 19,868 | 30,001 | 19,868 | |
Jun 19 2015 | DOR | SOLIGENIX, INC. | Brownlie Keith L | Director | Option Exercise | A | 1.51 | 19,868 | 30,001 | 19,868 | |
Jun 19 2015 | DOR | SOLIGENIX, INC. | Brughera Marco Maria | Director | Option Exercise | A | 1.51 | 19,868 | 30,001 | 19,868 | |
Jun 19 2015 | DOR | SOLIGENIX, INC. | RUBIN ROBERT J. | Director | Option Exercise | A | 1.51 | 19,868 | 30,001 | 19,868 | |
Jun 19 2015 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | A | 1.51 | 19,868 | 30,001 | 19,868 | |
Apr 09 2015 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | M | 0.61 | 17,857 | 10,893 | 0 | |
Apr 09 2015 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Buy | M | 0.61 | 17,857 | 10,893 | 66,666 | 48.8 K to 66.7 K (+36.59 %) |
Apr 09 2015 | DOR | SOLIGENIX, INC. | Brownlie Keith L | Director | Option Exercise | M | 0.61 | 14,286 | 8,714 | 0 | |
Apr 09 2015 | DOR | SOLIGENIX, INC. | Brownlie Keith L | Director | Buy | M | 0.61 | 14,286 | 8,714 | 50,000 | 35.7 K to 50 K (+40.00 %) |
Dec 24 2014 | DOR | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Option Exercise | P | 1.48 | 4,959 | 7,339 | 4,959 | |
Dec 24 2014 | DOR | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Buy | P | 1.21 | 8,265 | 10,001 | 75,761 | 67.5 K to 75.8 K (+12.25 %) |
Dec 24 2014 | DOR | SOLIGENIX, INC. | Warusz Joseph Michael | VP of Finance/Actin ... | Option Exercise | P | 1.48 | 4,959 | 7,339 | 4,959 | |
Dec 24 2014 | DOR | SOLIGENIX, INC. | Warusz Joseph Michael | VP of Finance/Actin ... | Buy | P | 1.21 | 8,265 | 10,001 | 12,955 | 4.7 K to 13 K (+176.23 %) |
Dec 08 2014 | DOR | SOLIGENIX, INC. | Straube Richard | Sr VP & Chief Medic ... | Option Exercise | A | 1.50 | 50,000 | 75,000 | 50,000 | |
Dec 08 2014 | DOR | SOLIGENIX, INC. | Warusz Joseph Michael | VP of Finance/Actin ... | Option Exercise | A | 1.50 | 45,000 | 67,500 | 45,000 | |
Dec 08 2014 | DOR | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Option Exercise | A | 1.50 | 100,000 | 150,000 | 100,000 | |
Aug 05 2014 | DOR | SOLIGENIX, INC. | Brughera Marco Maria | Director | Option Exercise | M | 2.01 | 7,500 | 15,075 | 7,500 | |
Aug 05 2014 | DOR | SOLIGENIX, INC. | Brughera Marco Maria | Director | Buy | M | 2.01 | 7,500 | 15,075 | 7,500 | 0 to 7.5 K |
Jun 20 2014 | DOR | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 2.19 | 13,669 | 29,935 | 13,669 | |
Jun 20 2014 | DOR | SOLIGENIX, INC. | Brownlie Keith L | Director | Option Exercise | A | 2.19 | 13,669 | 29,935 | 13,669 | |
Jun 20 2014 | DOR | SOLIGENIX, INC. | Brughera Marco Maria | Director | Option Exercise | A | 2.19 | 13,669 | 29,935 | 13,669 | |
Jun 20 2014 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | A | 2.19 | 13,669 | 29,935 | 13,669 | |
Jun 20 2014 | DOR | SOLIGENIX, INC. | RUBIN ROBERT J. | Director | Option Exercise | A | 2.19 | 13,669 | 29,935 | 13,669 | |
May 19 2014 | DOR | SOLIGENIX, INC. | Warusz Joseph Michael | VP of Admin, Contro ... | Option Exercise | M | 0.64 | 4,690 | 3,002 | 25,310 | |
May 19 2014 | DOR | SOLIGENIX, INC. | Warusz Joseph Michael | VP of Admin, Contro ... | Buy | M | 0.64 | 4,690 | 3,002 | 4,690 | 0 to 4.7 K |
May 16 2014 | DOR | SOLIGENIX, INC. | Brownlie Keith L | Director | Option Exercise | M | 0.30 | 16,667 | 5,000 | 8,333 | |
May 16 2014 | DOR | SOLIGENIX, INC. | Brownlie Keith L | Director | Buy | M | 0.30 | 16,667 | 5,000 | 35,714 | 19 K to 35.7 K (+87.50 %) |
May 14 2014 | DOR | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Option Exercise | M | 0.64 | 7,815 | 5,002 | 112,185 | |
May 14 2014 | DOR | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Buy | M | 0.64 | 7,815 | 5,002 | 67,496 | 59.7 K to 67.5 K (+13.09 %) |
Jan 08 2014 | DOR | SOLIGENIX, INC. | Straube Richard | Senior VP & CMO | Option Exercise | A | 2.01 | 100,000 | 201,000 | 100,000 | |
Dec 09 2013 | DOR | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Option Exercise | A | 2.01 | 100,000 | 201,000 | 100,000 | |
Dec 09 2013 | DOR | SOLIGENIX, INC. | Warusz Joseph Michael | VP of Finance and A ... | Option Exercise | A | 2.01 | 45,000 | 90,450 | 45,000 | |
Dec 09 2013 | DOR | SOLIGENIX, INC. | Brughera Marco Maria | Director | Option Exercise | A | 2.01 | 15,000 | 30,150 | 15,000 | |
Dec 09 2013 | DOR | SOLIGENIX, INC. | BREY ROBERT N | Chief Scientific Of ... | Option Exercise | A | 2.01 | 10,000 | 20,100 | 10,000 | |
Oct 01 2013 | DOR | SOLIGENIX, INC. | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 2.26 | 13,275 | 30,002 | 13,275 | |
Oct 01 2013 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | A | 2.26 | 13,275 | 30,002 | 13,275 | |
Oct 01 2013 | DOR | SOLIGENIX, INC. | RUBIN ROBERT J. | Director | Option Exercise | A | 2.26 | 13,275 | 30,002 | 13,275 | |
Oct 01 2013 | DOR | SOLIGENIX, INC. | Brownlie Keith L | Director | Option Exercise | A | 2.26 | 13,275 | 30,002 | 13,275 | |
Sep 27 2013 | DOR | SOLIGENIX, INC. | Warusz Joseph Michael | VP of Finance & Act ... | Option Exercise | A | 0.68 | 55,000 | 37,400 | 55,000 | |
Sep 27 2013 | DOR | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO & Pre ... | Option Exercise | A | 0.68 | 130,000 | 88,400 | 130,000 | |
Sep 27 2013 | DOR | SOLIGENIX, INC. | HORGAN KEVIN | Chief Medical Offic ... | Option Exercise | A | 0.68 | 85,000 | 57,800 | 85,000 | |
Sep 27 2013 | DOR | SOLIGENIX, INC. | BREY ROBERT N | Chief Scientific Of ... | Option Exercise | A | 0.68 | 35,000 | 23,800 | 35,000 | |
Jun 26 2013 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | P | 1.65 | 17,857 | 29,464 | 17,857 | |
Jun 26 2013 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Buy | P | 1.05 | 23,809 | 24,999 | 48,809 | 25 K to 48.8 K (+95.24 %) |
Jun 26 2013 | DOR | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Option Exercise | P | 1.65 | 7,143 | 11,786 | 7,142 | |
Jun 26 2013 | DOR | SOLIGENIX, INC. | SCHABER CHRISTOPHER J | Chairman, CEO and P ... | Buy | P | 1.05 | 9,523 | 9,999 | 59,681 | 50.2 K to 59.7 K (+18.99 %) |
Jun 26 2013 | DOR | SOLIGENIX, INC. | Brownlie Keith L | Director | Option Exercise | P | 1.65 | 14,286 | 23,572 | 14,285 | |
Jun 26 2013 | DOR | SOLIGENIX, INC. | Brownlie Keith L | Director | Buy | P | 1.05 | 19,047 | 19,999 | 19,047 | 0 to 19 K |
Jun 24 2013 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | M | 0.30 | 25,000 | 7,500 | 0 | |
Jun 24 2013 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Buy | M | 0.30 | 25,000 | 7,500 | 25,000 | 0 to 25 K |
Dec 21 2012 | DOR | SOLIGENIX, INC. | CAVAZZA PAOLO | 10% Owner | Option Exercise | J | 0.53 | 1 | 1 | 1 | |
Dec 21 2012 | DOR | SOLIGENIX, INC. | CAVAZZA PAOLO | 10% Owner | Option Exercise | J | 5.60 | 1 | 6 | 0 | |
Dec 21 2012 | DOR | SOLIGENIX, INC. | CAVAZZA PAOLO | 10% Owner | Option Exercise | J | 0.53 | 1 | 1 | 1 | |
Dec 21 2012 | DOR | SOLIGENIX, INC. | CAVAZZA PAOLO | 10% Owner | Option Exercise | J | 5.60 | 1 | 6 | 0 | |
Dec 21 2012 | DOR | SOLIGENIX, INC. | CAVAZZA PAOLO | 10% Owner | Option Exercise | J | 5.60 | 1 | 6 | 0 | |
Dec 21 2012 | DOR | SOLIGENIX, INC. | SIGMA TAU FINANZIARIA SPA | 10% Owner | Option Exercise | J | 0.53 | 1 | 1 | 1 | |
Dec 21 2012 | DOR | SOLIGENIX, INC. | SIGMA TAU FINANZIARIA SPA | 10% Owner | Option Exercise | J | 5.60 | 1 | 6 | 0 | |
Dec 21 2012 | DOR | SOLIGENIX, INC. | SIGMA TAU FINANZIARIA SPA | 10% Owner | Option Exercise | J | 5.60 | 1 | 6 | 0 | |
Jul 25 2012 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | A | 0.30 | 25,000 | 7,500 | 25,000 |